Alliance for Regenerative Medicine (ARM) | 2020 Cell & Gene Therapies State of the Industry

Sheila Mikhail, RhiaPharmaceutical CEO and co-founder, participated on the Next-Generation Gene and Cell Technologies panel at the ARM 2020 Cell & Gene Therapies State of the Industry briefing held on January 13, 2020 in San Francisco. She was joined by gene therapy leaders from Ziopharm Oncology, BlueRock Therapeutics and Senti Bio.